Sean Bohen, Olema Oncology CEO

Ole­ma On­col­o­gy re­ceives $180M in to­tal fund­ing

Ole­ma On­col­o­gy, the Bay Area biotech run by for­mer As­traZeneca ex­ec­u­tive Sean Bo­hen, raised $130 mil­lion from a pri­vate place­ment and a cred­it fa­cil­i­ty of up to $50 mil­lion from Sil­i­con Val­ley Bank to ad­vance its breast can­cer treat­ment.

The biotech an­nounced Tues­day that it can re­ceive $25 mil­lion once the place­ment clos­es on Sept. 12, with the re­main­ing funds be­ing able to be with­drawn at SVB’s dis­cre­tion.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.